Profile
Sector:
HealthcareIndustry:
Medical Instruments & SuppliesCountry:
United StatesIPO:
02 February 1995Website:
http://www.azenta.comNext earnings report:
08 August 2024Last dividends:
02 December 2021Next dividends:
N/APrice
after hours | Tue, 16 Jul 2024 21:03:22 GMTAnalysts recommendations
Institutional Ownership
AZTA Latest News
Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and SIRQC Clinical Registries BURLINGTON, Mass. , June 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Crohn's & Colitis Foundation (the "Foundation") as its sample management services provider for two of its large-scale prospective research cohorts, CAPTURE IBD and IBD SIRQC, which investigate pediatric and surgical care for Crohn's disease and ulcerative colitis.
BURLINGTON, Mass. , May 23, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Global Healthcare Conference in New York, NY, on Wednesday, June 5, 2024, which includes a presentation beginning at 11:00 am ET.
Robotics and automation are closely linked. Rising prices are causing problems for both consumers and business owners.
Azenta, Inc. (AZTA) Q1 2024 Earnings Call Transcript
In a somewhat quiet earnings lineup this week, several stocks stand out after posting strong quarterly results on Monday.
Azenta, Inc. (NASDAQ:AZTA ) Q4 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Sara Silverman - Head of IR Steve Schwartz - President and CEO Herman Cueto - CFO Conference Call Participants David Saxon - Needham Jacob Johnson - Stephens Andrew Cooper - Raymond James Paul Knight - KeyBanc Vijay Kumar - Evercore ISI Yuan Zhi - B. Riley Operator Thank you, and welcome to the Azenta Q4 2023 Financial Results.
Shares of Azenta Inc. AZTA, +0.59% jumped 11.9% after hours on Monday after the life-sciences company reported fourth-quarter results that beat expectations and announced plans to buy back an extra $500 million in stock in fiscal 2024. The company — whose products and services help researchers store, handle and process chemical and biological samples — reported net income of $3.4 million, or 6 cents a share, compared with a loss of $20.8 million, or 28 cents a share, in the same quarter last year.
Azenta, Inc., formerly Brooks Automation, sold its semiconductor business and subsequently became a pure play life science business. Azenta's shares have declined significantly and its valuation is still supported by net cash holdings. However, Azenta is not profitable, making it difficult to be optimistic about its shares.
Having activist investors at a company can lead to big changes. Azenta is dealing with an activist's call for better performance as it puts a giant cash hoard to work.
Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money.
What type of business is Azenta?
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
What sector is Azenta in?
Azenta is in the Healthcare sector
What industry is Azenta in?
Azenta is in the Medical Instruments & Supplies industry
What country is Azenta from?
Azenta is headquartered in United States
When did Azenta go public?
Azenta initial public offering (IPO) was on 02 February 1995
What is Azenta website?
https://www.azenta.com
Is Azenta in the S&P 500?
No, Azenta is not included in the S&P 500 index
Is Azenta in the NASDAQ 100?
No, Azenta is not included in the NASDAQ 100 index
Is Azenta in the Dow Jones?
No, Azenta is not included in the Dow Jones index
When was Azenta the previous earnings report?
No data
When does Azenta earnings report?
The next expected earnings date for Azenta is 08 August 2024